Science and Medicine

FDA approved retinal implant to treat blindness

26 September 2017 | Written by La redazione

The FDA has just granted approval to Second Sight Medical Products to begin human clinical study and trials of its newest visual prosthesis known as OrionThe maker of the world’s first commercial artificial retina, which provides partial sight to people with a certain form of blindness, is launching a clinical trial for a brain implant designed to restore vision to more patients.

Read more about this news

La redazione
La redazione

read more